Furthermore, Kim et al. studied the effect of 3-4 months of metformin treatment in T2DM subjects who failed glyburide treatment and noted no effect on basal or insulin-stimulated IRS1-associated PI3K or Akt activity in muscle cells. The gene discussed is IRS1; the disease is type 2 diabetes mellitus.